KLISBio
Bresso
About KLISBio
KLISBio is challenging the status quo in regenerative medicine by leveraging silk as a powerful, scalable and biocompatible scaffold material. We are targeting different clinical indications in the orthopaedic and vascular markets via several technology platforms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $13.0M
- Funding stage: Early Stage Venture
- Last round: Grant (Feb 2024)
- Website: klis.bio
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Life Science, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/klisbio-50478 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.